Views: 466 Author: Site Editor Publish Time: 2026-09-29 Origin: Site
If you source sodium hyaluronate for any commercial application — cosmetics, supplements, ophthalmic solutions, or injectables — molecular weight is the single most consequential specification on your COA. It determines where the molecule works in the body, how it behaves in formulation, and whether your product delivers on its claims.
Yet most buyers only look at the average molecular weight number and move on. That is like judging a paint job by the color name on the can while ignoring whether it is oil-based or water-based. The average number tells you part of the story. The full picture — molecular weight distribution, measurement method, and how those relate to your specific application — is what separates a good sourcing decision from an expensive mistake.
Sodium hyaluronate is a linear polysaccharide built from repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine. Each disaccharide unit adds approximately 400 Daltons to the chain. A molecule of 1,000 kDa contains roughly 2,500 repeating units; one of 10 kDa contains about 25. The same chemistry, just scaled.
That scale matters enormously. Molecular weight governs three things simultaneously:
Physical behavior. Higher molecular weight means higher viscosity at the same concentration. A 1% solution of 2,000 kDa sodium hyaluronate is dramatically more viscous than a 1% solution of 50 kDa material. This affects processing, filling, texture, and how the product feels on skin or in tissue.
Penetration depth. The stratum corneum acts as a size filter for topical applications. Molecules above approximately 500 kDa cannot cross intact skin. Molecules below 300 kDa penetrate into viable epidermal layers. Below 50 kDa, molecules can reach the deep epidermis. For non-topical routes — injection, oral ingestion — the penetration story is different, but molecular weight still determines biodistribution.
Biological signaling. This is where the science has evolved most in recent years. High molecular weight HA (above 1,000 kDa) interacts with CD44 receptors to produce anti-inflammatory and immunosuppressive effects. Low molecular weight fragments (below 100 kDa) can activate Toll-like receptors (TLR2/TLR4) and trigger pro-inflammatory pathways. This is not a theoretical distinction — it directly affects whether your product soothes or irritates inflamed tissue.
A landmark 60-day randomized controlled trial (Pavicic et al., 2011, PMID:22052267) tested five molecular weight fractions — 50, 130, 300, 800, and 2,000 kDa — at identical 0.1% concentrations in identical formulations. The 130 kDa fraction increased skin elasticity by 20% and produced statistically significant wrinkle depth reduction. The 50 kDa fraction also improved wrinkles. The 300, 800, and 2,000 kDa fractions improved surface hydration but did not significantly reduce wrinkle depth. This remains the most rigorous head-to-head molecular weight comparison published in the literature.
The commercially available range spans from under 5 kDa to over 3,000 kDa. Here is how the major fractions function:
MW Range | Category | Primary Mechanism | Key Applications |
<10 kDa | Oligomeric | Cell signaling, potential pro-inflammatory at high concentration | Advanced cosmeceuticals, drug delivery research |
10–100 kDa | Low MW | Deep epidermal penetration, fibroblast stimulation, collagen synthesis | Anti-aging serums, wound healing, dermal repair |
100–500 kDa | Medium-Low MW | Epidermal penetration with reduced inflammatory risk | Multi-depth hydration, daily skincare |
500–1,000 kDa | Medium MW | Surface + upper epidermis hydration, balanced performance | Moisturizers, essences, general skincare |
1,000–2,000 kDa | High MW | Surface film formation, anti-inflammatory (CD44), TEWL reduction | Barrier repair, sensitive skin, ophthalmic solutions |
>2,000 kDa | Ultra-High MW | Strong viscoelastic network, mechanical cushioning | Ophthalmic viscosurgical devices, joint injections |
For context, the hyaluronic acid in human synovial fluid (joint lubrication) has a molecular weight of 6,000–7,000 kDa. In the dermis, it sits at approximately 1,000 kDa. The body uses different molecular weights for different jobs — and so should your formulation.
An important caveat: oligomeric HA below 10 kDa acts as a damage-associated molecular pattern (DAMP) in the immune system. At high concentrations, it can trigger pro-inflammatory cytokine release via TLR2/TLR4. This is well-documented in isolated cell models. For cosmetic products containing low-MW fractions, the clinical significance at typical use concentrations (0.1–2%) remains unestablished — but it is worth knowing, particularly for products targeting inflamed or barrier-compromised skin.
The prevailing best practice in cosmetic formulation is multi-molecular-weight blending — combining two or three MW fractions to achieve both immediate surface hydration and longer-term structural benefits.
A typical strategy:
· High MW (1,000–1,800 kDa) at 40–60% of total HA content: surface film, immediate plumping, barrier protection
· Medium MW (100–500 kDa) at 20–30%: epidermal hydration, texture improvement
· Low MW (10–100 kDa) at 10–30%: deep hydration, fibroblast stimulation, anti-aging
Research published in the Journal of Cosmetic Science (2022) found that multi-weight formulations delivered 34% better hydration persistence at 8 hours post-application compared to single-weight alternatives at the same total HA concentration.
Recommended total HA concentrations: serums 0.5–2.0%, daily moisturizers 0.2–0.8%, eye creams 0.3–1.0%, sheet masks 0.1–0.5%. Concentrations above 1.5% total HA tend to produce undesirable tackiness without proportional hydration gains.
For oral consumption, the evidence suggests that molecular weights between 100–800 kDa offer the best absorption profile. Clinical trials on joint health and skin hydration typically use doses of 80–200 mg daily.
China approved sodium hyaluronate as a novel food ingredient in January 2021, permitting use in dairy products (≤0.2 g/kg), beverages, alcoholic drinks (≤1.0 g/kg), confections (≤3.0 g/kg), and frozen drinks (≤2.0 g/kg), with a recommended daily intake below 200 mg. The United States recognizes it as GRAS for similar applications.
Eye drops typically use sodium hyaluronate at 500–1,500 kDa, balancing viscosity with patient comfort. Ophthalmic viscosurgical devices (OVDs) used during cataract surgery require higher molecular weight material — typically 1,500–4,000 kDa — to maintain anterior chamber depth and protect the corneal endothelium during surgery.
All ophthalmic applications require endotoxin levels below 0.5 EU/mg, with leading manufacturers targeting below 0.05 EU/mg. Molecular weight selection must be paired with appropriate purity controls.
The clinical evidence strongly favors high molecular weight linear HA (above 2,000 kDa, ideally above 2.4 MDa) for intra-articular injection in osteoarthritis treatment. A 2025 review in PMC (PMID: PMC12561379) proposed a new two-tiered classification system for viscosupplementation products, distinguishing between:
· Linear HA (physiological, non-modified): subcategorized by MW into LMW (<1 MDa), IMW (1–2 MDa), and HMW (>2 MDa)
· Cross-linked HA (chemically modified hydrogels): ultra-high effective MW (>6 MDa)
High-concentration, high-molecular-weight linear HA (e.g., 2.5% at 2.4–3.6 MDa) has demonstrated sustained efficacy for up to one year in clinical trials, challenging the assumption that cross-linking is necessary for durability.
Injectable dermal fillers use cross-linked HA, typically at molecular weights above 1,000 kDa before cross-linking. The cross-linking process (most commonly using BDDE) creates a three-dimensional gel network that resists enzymatic degradation, extending persistence in tissue from weeks to 12–18 months. The choice of starting molecular weight, cross-linker type, and cross-linking density together determine the final product's G-prime (elasticity), cohesivity, and degradation rate.
Here is what most COAs do not tell you: the polydispersity index (PDI). PDI, calculated as Mw/Mn (weight-average molecular weight divided by number-average molecular weight), describes how broad the molecular weight distribution is around the reported average.
A PDI of 1.0 means every molecule in the sample is the same size. Real products typically have PDI values between 1.2 and 2.5. A product reported at "1,000 kDa average" with a PDI of 1.3 has a tightly controlled distribution — most molecules are close to 1,000 kDa. The same "1,000 kDa average" with a PDI of 2.5 could contain significant fractions of both 400 kDa and 2,000 kDa material — and the performance will be different.
Why does this matter?
Viscosity consistency. A broader distribution means batch-to-batch viscosity variation, even if the average MW is reported as identical. This affects filling accuracy, product texture, and consumer experience.
Performance predictability. If your formulation relies on a specific MW fraction for skin penetration (e.g., 130 kDa for anti-aging bioactivity), a broad distribution means the actual proportion of that target fraction varies between batches.
Regulatory compliance. The European Pharmacopoeia monograph for sodium hyaluronate specifies not just an average molecular weight but requires that the molecular weight distribution be consistent with the stated specification. USP similarly expects batch-to-batch consistency in MW distribution.
When you evaluate a supplier's COA, ask for the PDI value alongside the average MW. If they cannot provide it, or if PDI varies significantly between batches, that is a quality control gap worth addressing before committing to volume purchases.
Molecular weight of sodium hyaluronate is measured by Gel Permeation Chromatography (GPC), also called Size Exclusion Chromatography (SEC). The principle is straightforward: a solution of the sample passes through a column packed with porous beads. Larger molecules cannot enter the pores and elute faster; smaller molecules enter more pores and elute slower. By comparing elution times to known standards, the molecular weight distribution is calculated.
But the details matter:
Detector type. Most quality control labs use a Refractive Index (RI) detector. This is adequate for routine batch comparison but requires calibration with standards of known molecular weight — typically pullulan or HA reference standards. If the detector is calibrated with pullulan standards but reports HA molecular weight, there is an inherent conversion uncertainty.
The gold standard is Multi-Angle Laser Light Scattering (MALS) detection, which measures molecular weight absolutely — without reliance on calibration standards. MALS directly determines both the weight-average MW (Mw) and the number-average MW (Mn), enabling accurate PDI calculation.
What to look for on a COA:
· The detection method used (RI vs. MALS vs. both)
· The calibration standard (pullulan or HA)
· Whether the result is reported as Mw, Mn, or Mp (peak molecular weight)
· The PDI value (Mw/Mn)
· Ideally, a chromatogram or distribution curve
A COA that reports only "Molecular Weight: 1,200 kDa" without specifying the method, standard, or distribution is incomplete. It is not necessarily wrong, but it does not give you enough information to evaluate batch-to-batch consistency or compare meaningfully with another supplier's material.
Molecular weight is primarily determined during fermentation, but it can be modified during downstream processing. Understanding the control points helps you ask the right questions.
During fermentation:
· Strain selection sets the upper limit of achievable molecular weight. Streptococcus zooepidemicus naturally produces HA in the 500–3,000 kDa range. Recombinant Bacillus subtilis strains typically produce in the 1,000–1,500 kDa range.
· Fermentation conditions — temperature, pH, dissolved oxygen, nutrient feed rate — influence the molecular weight distribution within the strain's achievable range. Fed-batch processes generally achieve higher titers and tighter MW control than batch processes.
· Fermentation duration affects MW: longer fermentation can lead to enzymatic degradation of the polymer by bacterial hyaluronidases, reducing average MW.
During downstream processing:
· Enzymatic hydrolysis is deliberately used to produce low-MW fractions. Purified hyaluronidase cleaves HA chains at controlled points. The degree of hydrolysis determines the final MW.
· Mechanical stress during filtration, pumping, and drying can cause chain scission, particularly for ultra-high MW material. Gentle processing is essential for maintaining target MW.
· Heat exposure during drying degrades HA. Spray drying is faster but exposes material to higher temperatures; freeze-drying (lyophilization) preserves MW integrity at higher cost.
1. What is your fermentation strain, and is it well-characterized for safety?
2. Do you use batch or fed-batch fermentation? What is the typical titer?
3. Can you provide molecular weight data as a full distribution curve, not just an average?
4. What detection method do you use for MW measurement (RI or MALS)?
5. What is the typical PDI for each MW grade you supply?
6. What is your batch-to-batch MW coefficient of variation?
7. For low-MW grades, do you use enzymatic hydrolysis or mechanical/chemical degradation?
8. What drying method do you use, and how do you verify that MW is preserved post-drying?
Molecular weight is not a single number you pick from a catalog. It is a specification that determines how sodium hyaluronate behaves in your formulation, how it interacts with biological tissue, and what regulatory pathway your product follows.
Three actions will immediately improve your sourcing outcomes:
Define your target MW range based on application, not on what a supplier happens to offer. A skincare serum targeting anti-aging benefits needs different MW fractions than a viscosurgical device. Start with your product's functional requirements and work backward to the material specification.
Require complete molecular weight data, not just an average. Ask for PDI, detection method, calibration standard, and — ideally — a chromatogram. This is not unreasonable; it is standard pharmacopoeial practice.
Verify batch-to-batch consistency. A supplier who can deliver the right average MW once is not impressive. One who delivers the same MW distribution across 50 consecutive batches is a strategic partner.
Companies like Shandong Runxin Biotechnology demonstrate the level of molecular weight control that serious buyers should expect. With 28 years of dedicated fermentation expertise, Runxin offers a full MW spectrum from 3 kDa oligomeric HA to ultra-high molecular weight material exceeding 3,000 kDa. Every batch is characterized by GPC with multi-angle light scattering detection, with full molecular weight distribution data provided on each COA. Batch-to-batch MW coefficient of variation is maintained below 5%. Combined with a comprehensive certification portfolio (ISO 13485, CE, DMF 036368, COSMOS, HALAL, cGMP) and export experience across 34 countries, this is the kind of manufacturing rigor that turns a commodity raw material into a reliable competitive advantage.
The difference between a good product and a great one often lives in the details of the raw material. Molecular weight is where that difference starts.
Looking for sodium hyaluronate in a specific molecular weight range? Contact Runxin Biotechnology to discuss your application requirements and request COA samples for evaluation.
